Skip to main content
Clinical Trials/EUCTR2010-022897-14-DK
EUCTR2010-022897-14-DK
Active, Not Recruiting
Phase 1

A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the pre-MENAC study. - A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the

St. Olavs University Hospital0 sites12 target enrollmentMay 8, 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
lung cancer
Sponsor
St. Olavs University Hospital
Enrollment
12
Status
Active, Not Recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 8, 2013
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
St. Olavs University Hospital

Eligibility Criteria

Inclusion Criteria

  • Lung cancer
  • Have a staging CT within 4 weeks of commencement of chemotherapy or chemoradiotherapy (in patients where staging CT is outwith this period, further CT scanning will be undertaken. PET\-CTs are also appropriate)
  • 18–75years of age
  • about to start chemotherapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 10
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 2

Exclusion Criteria

  • Renal impairment (serum albumin \< 25 g/L or Child\-Pugh \=10 (pancreatic cancer patients only)), creatinine clearance \<30ml/min (estimated using cockroft\-gault, creatinine measured within two months of date of consent)
  • Patients who are taking either aspirin, NSAID or Cox 2 inhibitors prior to study entry
  • Women during pregnancy, breastfeeding or who are of child\-bearing potential (that is not postmenopausal or permanently sterilised) age and who do not use adequate contraception (oral, injected or implanted or hormonal methods of contraception’s, intrauterine device and barrier method)

Outcomes

Primary Outcomes

Not specified

Similar Trials